Product
GFT505
1 clinical trial
1 indication
Indication
Non-Alcoholic SteatohepatitisClinical trial
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).Status: Completed, Estimated PCD: 2015-02-01